title: Updating on Italian stroke units: the "CCM study".
abstract: The stroke units (SUs) have been demonstrated to be efficient and cost effective for acute stroke care. Nevertheless, the level of stroke unit implementation in Italy does not correspond to expectations yet. This study is a survey, which aims at assessing the current status of in-hospital stroke care in the Italian regions and at updating SUs. The survey was conducted by means of a semi-structured questionnaire, based on 18 stroke care "quality indicators", submitted to all the Italian centres that had taken part in the SITS-MOST study, and to other centres advised by the coordinator of SITS studies and by regional opinion leaders of stroke. SUs were defined as acute wards, with stroke-dedicated beds and dedicated teams that had been formally authorised to administer rt-PA. A statistical analysis was performed by a descriptive statistics and logistic regression model. The study was carried out from November 2009 to September 2010. A total of 168 forms were sent out and 153 replies received. Seven centres, which had not performed any thrombolytic treatment, and 16 which did not fulfil the criteria for the definition of SU were excluded from the study. Most of the centres reported more than 100 stroke patient admissions per year, i.e., 122 (84%) from 100 to 500, 18 (12%) more than 500. The 19% of the centres admitted more than 30% of patients within 3 h from the symptom onset and only 30% admitted more than 30% of patients within 4.5 h. The mean number of thrombolyses performed in the last 6 months was 10 for centres with a doctor on duty 24 h a day, 6 for those that have a doctor on duty from 8 a.m. to 8 p.m. and a doctor on call for night, and 5 for centres with a doctor on call 24 h a day. The territorial distribution of the SUs is remarkably heterogeneous: 87 SUs (67%) are located in the North of Italy, 28 (22%) in the central part of Italy and only 15 (11%) in the South. The last few years have witnessed a rise in both the diffusion of SUs and access to thrombolytic therapy in Italy. Despite this, there are a few large areas, mostly in the south, where the requirements of healthcare legislation are not met, and access to a dedicated SU and thrombolytic treatment is still limited and poor.
authors.affiliation: Department of Neurology, G. da Saliceto Hospital, Via Cantone del Cristo, 29100 Piacenza, Italy. d.guidetti@ausl.pc.it
authors.forename: D
authors.initials: D
authors.lastname: Guidetti
authors.forename: M
authors.initials: M
authors.lastname: Spallazzi
authors.forename: D
authors.initials: D
authors.lastname: Toni
authors.forename: E
authors.initials: E
authors.lastname: Rota
authors.forename: N
authors.initials: N
authors.lastname: Morelli
authors.forename: P
authors.initials: P
authors.lastname: Immovilli
authors.forename: M
authors.initials: M
authors.lastname: Baldereschi
authors.forename: B M
authors.initials: BM
authors.lastname: Polizzi
authors.forename: S
authors.initials: S
authors.lastname: Ferro
authors.forename: D
authors.initials: D
authors.lastname: Inzitari
mesh_terms: D006757:Hospital Units / Q000639:trends*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D011795:Surveys and Questionnaires; D015912:Thrombolytic Therapy / Q000639:trends*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D010959:Tissue Plasminogen Activator